Understanding the use of SGLT2 inhibitors for the management of Type 2 Diabetes

General practice staff and students are invited to attend a case-based learning series focused on the management of CV risk in type two diabetes with SGLT2 inhibitors. Participants will hear from and join in conversation with, colleagues in general practice as they discuss approaches to the management of diabetes with this medication class including in complex patients with comorbidities.

Presented by Future Health Today (Department of General Practice, The University of Melbourne), the three sessions will take place via Zoom on Thursday evenings across July-August 2022 using the Project ECHO model. View further details via the registration link.